53

Panchsheel Organics LtdBOM 531726 Stock Report

Last reporting period 31 Mar, 2024

Updated 13 Nov, 2024

Last price

Market cap $B

0.004

Micro

Exchange

XBOM - Bombay Stock Exchange

531726.BO Stock Analysis

53

Neutral

Based on Eyestock quantitative analysis, 531726.BO`s fundamental data and valuation indicate an investment grade of Neutral at the current time.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

64/100

Moderate score

Upside

To determine whether the current price is a reasonable to buy a stock, we compare it to our estimate of fair value. The more undervalued a stock is, the higher the upside.

-23.7 %

Overvalued

Market cap $B

0.004

Dividend yield

1.06 %

Shares outstanding

13.17 B

Panchsheel Organics Ltd. engages in the manufacture of pharmaceuticals and medicinal chemical products. The company is headquartered in Mumbai, Maharashtra and currently employs 180 full-time employees. Its specialties include steroids and hormones, veterinary products, over-the-counter products, oncology products, nutraceutical products, micro pellets and direct compression granules, fitness and healthcare, and product development and testing laboratory. The firm offers a range of products under categories, such as cardiovascular, neuropsychiatry, anti-fungal, fluoroquinolones, antiallergic, anti-inflammatory, gastrointestinal, osteoporosis and erectile dysfunction, among others. Its API product range includes Acamprosate Calcium, Amiodarone, Leflunomide, and others. Its hormones and steroids product range includes Cyproterone Acetate, Desogestrel and others. Its nutraceuticals and healthcare products include Alpha Linolenic Acid (ALA) Powder, Phytosterol, and others.

View Section: Eyestock Rating